XML 92 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation and Other Benefit Plans - Fair Value of Each Award Estimated on Date of Grant Using Black-Scholes-Merton Option-Pricing Formula (Detail) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Performance Restricted Stock Units      
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]      
Expected volatility, min 131.74% 101.32%  
Expected volatility, max 134.74% 117.71%  
Expected volatility     49.90%
Dividend yield 0.00% 0.00% 0.00%
Risk-free interest rate, min 0.22% 0.18%  
Risk-free interest rate, max 0.29% 0.51%  
Risk-free interest rate     1.66%
Average grant-date fair value (in dollars per share) $ 22.44    
Granted (in shares) 225,206 145,399 15,066
Performance Shares | Share-based Payment Arrangement, Tranche One      
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]      
Average grant-date fair value (in dollars per share)     $ 34.02
Performance Shares | Share-based Payment Arrangement, Tranche One | Minimum      
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]      
Average grant-date fair value (in dollars per share) $ 17.74 $ 2.40  
Performance Shares | Share-based Payment Arrangement, Tranche One | Maximum      
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]      
Average grant-date fair value (in dollars per share) 33.31 $ 16.02  
ROCE      
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]      
Average grant-date fair value (in dollars per share) $ 13.63